Purpose: To assess the long-term stability of the anchored radiofrequency transponders and compare displacement rates with other commercially available lung fiducial markers. We also sought to describe late toxicity attributable to fiducial implantation or migration.
| INTRODUCTION
Stereotactic body radiation therapy (SBRT) has revolutionized the treatment of early stage non-small cell lung cancer (NSCLC) for medically inoperable patients, and those who decline surgical resection. Since SBRT requires delivery of ablative radiation doses with steep dose gradients, accounting for target motion is critical. Early lung SBRT techniques required large internal target volume (ITV) expansions in order to account for target motion throughout the respiratory cycle. 1 As SBRT utilization has evolved, a number of techniques have been developed to reduce the amount of normal lung tissue within the treatment volume. Respiratory gating is commonly utilized to restrict treatment delivery to only a portion of the respiratory cycle, typically near end-expiration, and therefore reducing the necessary ITV margin. 2 A potential concern with respiratory gating is that many gating systems rely on the position of an external marker, which has the potential to be a poor surrogate for target motion. [3] [4] [5] To mitigate the concern that movement of the gating marker and tumor may be discordant, real time radiographic tracking of implanted fiducial markers can be combined with respiratory gating.
The use of triggered planar imaging to assess fiducial marker position improves the accuracy of treatment delivery, 6 but this technique has a number of limitations. For instance, the tumor is periodically assessed rather than continuously monitored, treatment delivery remains tied to the respiratory cycle rather than tumor position, and fiducial deviation is assessed visually and therefore subject to human error. In order to overcome these limitations, the Calypso ® System (Varian Medical Systems, Palo Alto, CA, USA) has been suggested as a potential solution. 7 The Calypso System consists of electromagnetic transponders paired with a detector array. The Calypso System has been validated for providing real-time tumor tracking within a variety of solid tissues. 8 In order to extend this technology to lung tumor localization, a 5-legged nitinol stabilization system has been developed to anchor the transponders within the lung tissue. The anchored transponders are placed within small airways, on the order of 2 mm diameter, via navigational bronchoscopy. The short-term stability and accuracy of anchored transponders was recently the subject of a prospective clinical trial, but no long-term stability and safety data have yet been reported. The purpose of this study was to assess the long-term stability of anchored transponders. We also sought to describe late toxicity attributable to fiducial implantation or migration. Finally, we compared migration rates with other commercially available lung fiducial markers as a surrogate for the possibility of unexpected future clinical manifestations.
| MATERIALS AND METHODS

2.A | Patient cohorts
The transponder cohort consisted of all patients at our institution who underwent placement of anchored transponders into small airways as part of a prospective clinical trial (NCT01396551); no patients who underwent transponder placement were excluded. A 
2.C | Assessment of fiducial movement
The simulation CT scan was considered as the reference image for baseline fiducial location. On the 4-dimensional simulation CT data set, the implanted markers were manually segmented on the earliest phase of the respiratory cycle for which treatment was planned (corresponding to when the treatment gate opens) using Varian Eclipse software and a uniform 5 mm spherical expansion structure around each marker was generated (depicted in red in Figs. 1-3 ). The most recent CT scan, up to 2.5 yr post-SBRT, was then imported for registration to the simulation CT scan. Scans beyond 2.5 yr in the comparison cohort were not considered since no patient within the transponder cohort had been followed longer than that period of time. The follow-up CT scan was then rigidly registered to the simulation scan (Fig. 1 ). Registration methods consisted of a rigid 3-point registration to the fiducial markers with manual adjustments allowed.
Unreasonable distortion of patient anatomy (eg, 90 degree rotation)
was not allowed. Fiducial displacement was said to have occurred if the follow-up CT could not be registered in such a way that all markers were within the 5 mm sphere around the initial position.
The 5 mm threshold to define displacement was based on the investigators' judgment regarding the magnitude of fiducial position changes that were not likely due to respiratory motion or CT acquisition technique.
For cases where marker displacement was noted, the follow-up CT scan was further assessed to determine whether the displaced marker(s) was located within an area of fibrosis or normal appearing lung parenchyma. In each case, whether marker displacement was most likely due to evolving postradiation fibrosis (Fig. 2) or to migration ( Fig. 3 ) was recorded. Of the six patients with marker displacement within the transponder group, five instances appeared to be related to radiation fibrosis around one or more transponders. Of the 11 patients with fiducial displacement within the comparison group, four instances of fiducial displacement appeared to be related to progressive radiation fibrosis.
2.D | Analysis and regulatory review
3.C | Toxicity
No patient within either group developed a pneumothorax at any time point. One patient in the transponder group experienced gross hemoptysis approximately 1 yr from fiducial implantation, but bronchoscopic evaluation confirmed the bleeding was due to local tumor recurrence.
No patient in the comparison group experienced gross hemoptysis.
| DISCUSSION
The Calypso System utilizing electromagnetic transponders has multiple characteristics that offer potential advantages over current One patient with two transponders placed in LUL and one in LLL was treated as LUL for purposes of case matching.
second. 11 Decreased target position uncertainty should allow for a reduction in ITV and PTV margins and therefore reduce the amount of nontumor tissue within the treatment volume. When combined with the Dynamic Edge Gating system, the Calypso System obviates the need for an external surrogate gating marker since a beam-hold is imposed if the transponders move beyond a prespecified margin.
Gating treatment delivery based on target position rather than the respiratory cycle may also improve the overall efficiency of treatment, particularly for patients with irregular respirations, by reducing unnecessary beam-holds.
Anchored transponders are placed via bronchoscopy and utilize a 5-legged nitinol stabilization system to aid retention. 12 Preliminary evidence supports the short-term stability and accuracy of the anchored transponders. 13 Fixation of the transponders for up to 60 days was similar to that of spherical gold markers in a canine model, 14 Rates of acute pneumothorax exceeding 20% were initially described in early series that utilized trans-thoracic fiducial placement techniques, 17, 18 but this has become rare in the era of bronchoscopic placement. The fact that no patient in this series devel- 
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